Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 13/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL219862 | 1.00 | HSD11B1 (0.36) | HSD11B1ACHEKMT2ACNR2ALDH1A1 | |
| SCHEMBL384343 | 0.96 | ALDH1A1 (0.34) | HSD11B1ACHEKMT2ACNR2ALDH1A1 | |
| SCHEMBL447472 | 0.87 | ACHE (0.35) | HSD11B1ACHEKMT2ACNR2ALDH1A1 | |
| SCHEMBL384824 | 0.87 | NR1I2 (0.34) | HSD11B1ACHEKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL217323 | 0.85 | ALDH1A1 (0.32) | HSD11B1CNR2ALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL6339986 | 0.85 | CNR2 (0.31) | CNR2 | |
| SCHEMBL4480664 | 0.83 | NR1I2 (0.32) | — | |
| SCHEMBL384856 | 0.82 | — | — | |
| SCHEMBL447468 | 0.82 | PTGS2 (0.33) | CNR2 | |
| SCHEMBL4852337 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088548-B2 | Bottom antireflective coating compositions | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20090104559-A1 | Bottom Antireflective Coating Compositions | MERCK PATENT GMBH (DE) | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104559-A1 | Bottom Antireflective Coating Compositions | SDC2, S100A9, MYH9 | HSD11B1 4015/4885ACHE 3212/4885KMT2A 1852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.